全文获取类型
收费全文 | 243190篇 |
免费 | 21659篇 |
国内免费 | 11000篇 |
专业分类
耳鼻咽喉 | 2533篇 |
儿科学 | 5523篇 |
妇产科学 | 2653篇 |
基础医学 | 42740篇 |
口腔科学 | 6084篇 |
临床医学 | 18848篇 |
内科学 | 40710篇 |
皮肤病学 | 5859篇 |
神经病学 | 12147篇 |
特种医学 | 5297篇 |
外国民族医学 | 135篇 |
外科学 | 18507篇 |
综合类 | 36489篇 |
现状与发展 | 68篇 |
预防医学 | 10124篇 |
眼科学 | 4139篇 |
药学 | 21370篇 |
47篇 | |
中国医学 | 8385篇 |
肿瘤学 | 34191篇 |
出版年
2024年 | 393篇 |
2023年 | 3169篇 |
2022年 | 5605篇 |
2021年 | 8456篇 |
2020年 | 7672篇 |
2019年 | 7681篇 |
2018年 | 7721篇 |
2017年 | 8009篇 |
2016年 | 8589篇 |
2015年 | 9763篇 |
2014年 | 14699篇 |
2013年 | 16024篇 |
2012年 | 14349篇 |
2011年 | 15716篇 |
2010年 | 12966篇 |
2009年 | 12555篇 |
2008年 | 13033篇 |
2007年 | 13174篇 |
2006年 | 12036篇 |
2005年 | 10832篇 |
2004年 | 9391篇 |
2003年 | 8142篇 |
2002年 | 6721篇 |
2001年 | 5819篇 |
2000年 | 4750篇 |
1999年 | 4245篇 |
1998年 | 3942篇 |
1997年 | 3555篇 |
1996年 | 3158篇 |
1995年 | 2836篇 |
1994年 | 2512篇 |
1993年 | 2037篇 |
1992年 | 1768篇 |
1991年 | 1611篇 |
1990年 | 1293篇 |
1989年 | 1190篇 |
1988年 | 1092篇 |
1987年 | 870篇 |
1986年 | 800篇 |
1985年 | 1265篇 |
1984年 | 1170篇 |
1983年 | 861篇 |
1982年 | 903篇 |
1981年 | 735篇 |
1980年 | 643篇 |
1979年 | 540篇 |
1978年 | 392篇 |
1977年 | 298篇 |
1976年 | 286篇 |
1975年 | 195篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
102.
《Journal of vascular and interventional radiology : JVIR》2020,31(5):760-768.e1
PurposeTo investigate dynamic variables obtained from retrospective computed tomography angiography for ability to predict thoracic endovascular aortic repair (TEVAR) outcomes in patients with complicated type B aortic dissection (cTBAD).Materials and MethodsSeventy-nine patients with cTBAD who received TEVAR from March 2009 to June 2018 were retrospectively enrolled. Relative true lumen area (r-TLA) was computed at the level of tracheal bifurcation every 5% of all R-R intervals. Parameters that reflect the state of intimal motion were evaluated, including difference between maximum and minimum r-TLA (D-TLA) and true lumen collapse. The endpoints comprised early (≤ 30 days) and late (> 30 days) outcomes after intervention.ResultsOverall early mortality rate was 13.9% (11/79), and early adverse events rate was 24.1% (19/79). Patients who received TEVAR within 2 days of symptom onset demonstrated the worst outcomes. A longer time of r-TLA < 25% in 1 cardiac cycle (P = .049) and larger D-TLA (P < .001) were correlated to an increased early death. In addition, D-TLA was an independent predictor of early mortality. Area under the curve of D-TLA was 0.849 (95% confidence interval 0.730–0.967) for predicting early mortality and 0.742 (95% CI 0.611–0.873) for predicting early adverse events. Survival and event-free survival rates during follow-up were decreased in the D-TLA > 21.5% group compared with the D-TLA ≤ 21.5% group (all P < .001).ConclusionsLarger D-TLA is correlated with worse postoperative outcomes and might be a crucial parameter for future risk stratification in patients with cTBAD. 相似文献
103.
104.
《Neuro-Chirurgie》2022,68(2):196-201
BackgroundTumor-to-tumor metastases are extremely rarely reported lesions, which usually involve an indolent lesion hosting a more aggressive neoplasm. We present an unusual initial manifestation of a previously unknown clear cell renal cell carcinoma as a tumor-to-tumor metastasis in a typical meningothelial meningioma.Case reportA 73-year old patient with transient left slight monoparesis was addressed to our Neurosurgical Department after being evaluated by his general practitioner and passing a cerebral MRI which revealed a right frontotemporal mass attached to the meninge. At presentation, no deficits were identified; therefore an elective surgery was proposed. Histological analysis revealed a typical meningothelial meningioma containing a metastatic clear cell renal cell carcinoma. Additional thoraco-abdominal computer tomography identified a 6 cm diameter lesion within the right kidney with radiological features highly suggestive of a primary clear cell renal cell carcinoma.ConclusionOur case highlights the need for a specialized neuropathological approach to clinical and imagistic indolent meningiomas, as they may require important differential diagnosis that can highly impact the treatment and follow-up of brain tumor patients. 相似文献
105.
I Ahmad 《Annals of the Royal College of Surgeons of England》2015,97(7):481-486
Urothelial cell carcinoma (UCC) of the bladder is one of the most common malignancies, causing considerable morbidity and mortality worldwide. It is unique among the epithelial carcinomas as two distinct pathways to tumourigenesis appear to exist: low grade, recurring papillary tumours usually contain oncogenic mutations in FGFR3 or HRAS whereas high grade, muscle invasive tumours with metastatic potential generally have defects in the pathways controlled by the tumour suppressors p53 and retinoblastoma. Over the last two decades, a number of transgenic mouse models of UCC, containing deletions or mutations of key tumour suppressor genes or oncogenes, have helped us understand the mechanisms behind tumour development. In this summary, I present my work investigating the role of the WNT signalling cascade in UCC. 相似文献
106.
107.
108.
目的 分析CSTB、A-FABP在膀胱癌诊断和预后的意义。方法 选取2014年1月至2016年7月在本院进行手术、病理证实的膀胱癌患者45例、良性膀胱病变患者88例,检测膀胱癌样本癌组织、癌旁组织、良性膀胱病变组织中CSTB、A-FABP表达水平。评价CSTB、A-FABP在鉴别诊断膀胱癌的效用。对比膀胱癌进展对象(2年内转移、复发、肿瘤死亡)以及未进展对象组织中CSTB、A-FABP表达水平。结果 癌组织、癌旁组织、良性病变对象组织中CSTB、A-FABP表达水平差异有统计学意义(P<0.05)。CSTB、A-FABP作为诊断标准(任意一项为阳性),鉴别诊断膀胱癌与良性病变的灵敏度为84.4%、特异度为90.9%、阳性预测值82.6%、阴性预测值92.0%、符合率88.7%。2年内转移、复发、肿瘤死亡的患者共30例,无转移、复发、死亡的患者共15例,膀胱癌进展对象CSTB、A FABP表达量高于未进展对象,差异有统计学意义(P<0.05)。结论 CSTB、A-FABP在膀胱癌诊断、预后预测中均有一定的临床价值。 相似文献
109.
110.
《药学学报(英文版)》2020,10(7):1294-1308
A great challenge in multi-targeting drug discovery is to identify drug-like lead compounds with therapeutic advantages over single target inhibitors and drug combinations. Inspired by our previous efforts in designing antitumor evodiamine derivatives, herein selective histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) dual inhibitors were successfully identified, which showed potent in vitro and in vivo antitumor potency. Particularly, compound 30a was orally active and possessed excellent in vivo antitumor activity in the HCT116 xenograft model (TGI = 75.2%, 150 mg/kg, p.o.) without significant toxicity, which was more potent than HDAC inhibitor vorinostat, TOP inhibitor evodiamine and their combination. Taken together, this study highlights the therapeutic advantages of evodiamine-based HDAC1/TOP2 dual inhibitors and provides valuable leads for the development of novel multi-targeting antitumor agents. 相似文献